Company Website

Contact Information:

Michael Carr
mike.carr@adctherapeutics.com 
612.308.6317

Virtual Exhibit Hall Home

ADC Therapeutics. Confronting cancer with the full potential of our science.
ADC Therapeutics is a commercial-stage biotechnology company improving the lives of cancer patients with next-generation, targeted antibody drug conjugates (ADCs). ADC therapeutics is advancing its proprietary PBD-based ADC technology to transform the treatment paradigm for patients with hematologic malignancies and solid tumors.

Additional Information:

Zynlonta (Loncastuximab tesirine-lpyl) NOW APPROVED!
Zynlonta (Loncastuximab tesirine- lpyl) Dosing & Administration
Zynlonta (Loncastuximab tesirine-lpyl) Prescribing Information